СИНДРОМ БРУГАДА И БРУГАДОПОДОБНЫЕ ИЗМЕНЕНИЯ ЭКГ ПРИ ЛЕЧЕНИИ ПСИХОТРОПНЫМИ ПРЕПАРАТАМИ
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Полный текст:
Аннотация
Анализируется современная литература, посвященная врожденному и приобретенному синдрому Бругада, приводится собственное наблюдение приобретенного синдрома Бругада у больной психиатрической больницы.
Список литературы
1. O’Brien P, Oyebode F. Psychotropic medication and the heart. // Advances in Psychiatric Treatment. 2003; 9: 414423.
2. Buckley N.A., Sanders P. Cardiovascular Adverse Effects of Antipsychotic Drugs // Drug Safety 2000; 23(3): 215-228.
3. Abdelmawla N., Mitchel A.J. Sudden cardiac death and antipsychotics // Advances in Psychiatric Treatment 2006; 12:35-44; 100-109.
4. Wilens T.E., Biederman J., Baldessarini R.J. et al. Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. // J Am Acad Child Adolesc Psychiatry 1996; 35: 1491-1501.
5. Herxheimer A., Healy D. Arrythmias and sudden death in patients taking antipsychotic drugs. // BMJ 2002; 325: 1253-1254.
6. Ray W. A., Meredith S., Thapa P. B. et al. Antipsychotics and the risk of sudden cardiac death. // Archives of General Psychiatry 2001; 58:1161-1167.
7. Liperotti R., Gambassi G., Lapane K. L. et al. Conventional and atypical antipsychotics and risk of hospitalization for ventricular arrhythmias or cardiac arrest. // Archives of Internal Medicine 2005; 165: 696-701.
8. Mehtonen O.P., Aranki K., Malkonen L. et al. A servey of sudden deth associated with the use of antipsychotics or antidepressant drugs: 49 cases in Finland. // Acta Psychiatrica Scand, 1991; 84: 58-64.
9. FDA issues public health advisory for antipsychotic drugs used for treatment of behavioral disorders in elderly patients (FDA talk Paper) Rochvill (MD): US Food and Drug Administration (2006).
10. Brugada P., Brugada R., Antzelevitch C., Brugada J. The Brugada syndrome // Arch Mal Coeur Vaiss 2005; 98(2): 115-122.
11. Brugada P., Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. // J Am Coll Cardiol 1992; 20: 1391-1396.
12. Di Diego J.M.,Cordeiro J.M., Goodrow R.J. et al. Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. // Circulation 2002; 106: 2004-2011.
13. Antzelevitch C., Brugada P., Borggrefe M. et al. Brugada syndrome. Report of the second consensus conference. // Circulation 2005; 111: 659-670.
14. Brugada J., Brugada R., Brugada P. Brugada syndrome. // Arch Mal Coeur Vaiss 1999; 92: 847-850.
15. Shimizu W., Aiba T., Kurita T., Kamakura S. Paradoxic abbreviation of repolarization in epicardium of the right ventricular outflow tract during augmentation of Brugada-type ST segment elevation. // J Cardiovasc Electrophysiol 2001; 86: 161-166.
16. Brugada J., Brugada R., Brugada P. Channelopathies: a new category of diseases causing sudden death. // Herz 2007; 32(3):185-191.
17. Chen Q., Kirsch G.E., Zhang D. et al. Genetic basis and molecular mechanisms for idiopathic ventricular fibrillation. // Nature 1998; 392 : 293-296.
18. Smits JP, Eckardt L, Probst V et al. Genotype-phenotype relationship in in Brugada syndrome: electrocardiographic features differentiale SCN5A-related patiets from nonSCN5A-related patients. // JACC 2002; 40: 350-356.
19. Schulze-Bahr E., Eckardt L., Breithardt G. et al. Sodium channel gene (SCN5A) mutation in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease. // Hum Mutat 2003; 21: 651-652.
20. Antzelevitch C. The Brugada syndrome: ionic basis and arrhythmia mechanisms. // J Cardiovascular Electrophysiol 2001; 12: 268-272.
21. Tan H.L., Kupershmidt S., Zhang R. et al. A calcium sensor in the sodium channel modulates cardiac excitability. // Nature 2002; 415: 442-447.
22. Baroudi G., Pouliot V., Denjoy I et al. Novel mechanism for Brugada syndrome: defective surface localization of an SCN5A mutant (R1432G). // Circ Res 2001; 88: E78-E83.
23. Kurita T., Shimizu W., Inagaki M. et al. The Electrophysioligic mechanism of ST-segment elevation in Brugada syndrome. // J Am Coll Cardiol 2002; 40: 330-334.
24. Yan G.X., Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. // Circulation 1999; 100: 1660-1666.
25. Kasanuki H., Ohnishi S., Matuda N., Nirei T. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. // Circulation 1997; 95: 2277-2285.
26. Wichter T., Matheja P., Eckardt L. et al. Cardiac autonomic dysfunction in Brugada syndrome. // Circulation 2002; 105: 702-706.
27. Matsuo K., Kurita T., Inagaki M et al. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. // Eur Heart J 1999; 20: 465-470.
28. Miyazaki T., Mitamura H., Miyoshi S et al. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. // J Am Coll Cardiol 1996; 27: 1061-1070.
29. Priori S.G., Allot E., Blomstrom-Lundqvist C. et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. // Eur Heart J 2001; 22: 1374-1450.
30. Ватутин Н.Т., Склянная Е.В. Синдром Бругада. // Кардиология 2003; 11: 80-85.
31. Генерозов Э.В., Гиляров Н. А., Новикова М.В. и др. Синдром Бругада: обзор литературы и клиническое наблюдение необычного течения заболевания // Кардиология 2006; 46(9): 77-87.
32. Unlu M., Bengi F., Amasyali B., Kose S. Brugada-like electrocardiographic changes induced by fever. // Emerg Med J. 2007; 24(1): e4.
33. Shimizu W., Matsuo K., Kokubo Y. et al. Sex hormone and gender difference-role of testosterone on male predominance in Brugada syndrome // J Cardiovasc Electrophysiol 2007; 18(4): 415-421.
34. Littmann L., Monroe M.H., Taylor L.et al. The hyperkalemic Brugada sign. // J Electrocardiol 2007; 40(1): 5359.
35. Wu L.S., Wu C.T., Hsu La et al. Brugada-like electrocardiographic pattern and ventricular fibrillation in a patient with primary hyperparathyroidism. // Europace 2007; 172-174.
36. Ortega-Camicer J., Bertos-Polo J., Gutierrez- Tirado C. Aborted sudden death, transient Brugada pattern and wide Qrs dysrrhythmias after massive cocaine ingestion. / / J Electrocardiol 2001; 34: 345-349.
37. Ozeke O., Selsuk M.T.,Topaloglu S. et al. Brugada-like early repolarisation pattern associated with acute pericarditis // Emerg Med J 2006; 23(12): 957-959.
38. Roberts-Thomson K.S., Teo K.S., Young G.D. Drug-induced Brugada Syndrome with ST-T wave alternans and long QT. // Intern Med J 2007; 37(3): 199-200.
39. Hermida J-S., Six I., Jarry G. Drug-induced pericarditis mimicking Brugada syndrome // Europace 2007; 9(1): 66-68.
40. Wataru & Shimizu. Gender Difference and Drug Challenge in Brugada syndrome // J Cardiovasc Electrophysiol 2004; 15: 70-71.
41. Aouate P., Clerc J., Viard P., Seoud J. Propranolol intoxication revealing a Brugada syndrome // J Cardiovasc Electrophysiol 2005; 16(3): 348-351.
42. Rouleau F., Asfar P., Boulet S. et al. Transient ST segment elevation in right precardial leads induced by psychotropic drugs: relationship to the Brugada syndrome. // J Cardiovasc Electrophysiol 2001; 12: 61-65.
43. Goldgran-Toledano D., Sideris G., Kevorkian J. Overdose of cyclic antidepressants and the Brugada syndrome. // N Engl J Med 2002; 346: 1591-1592.
44. Shah S.U., Iqbal Z., White A., White S. Heart and mind: psychotropic and cardiovascular therapeutics. // Postgrad Med J 2005; 81: 33-40.
45. Thanacoody, Ruben H.K., Thomas, Simon H.L. Tricyclic Antidepressant Poisoning: Cardiovascular Toxicity. Review Article. // Toxicological Reviews 2005; 24: 3.
46. Brahmi N., Thabet H., Kouraichi N. et al. Brugada syndrome and other cardiovascular abnormalities related drugs intoxication // Arch Mal Coer Vaiss 2007; 100(1): 28-33.
47. Akhtar M., Goldschlager N.F. Brugada electrocardiographic pattern due to tricyclic antidepressant overdose. // J Electrocardiol 2006; 39(3): 336-339.
48. Bebarta V.S., Waksman J.C. Amitriptyline-induced Brugada pattern fails to respond to sodium bicarbonate. // Clin Toxicol (Phila) 2007; 45(2): 186-188.
49. Darbar D., Yang T., Churchwell K. et al. Unmasking of Brugada syndrome by lithium. // Circulation 2005; 112(11): 1527-1531.
50. Al Aloul B., Adabag A.S., Houghland M.A., Tholakanahalli V. Brugada pattern electrocardiogram associated with supratherapeutic phenytoin levels and the risk of sudden death. // Pacing Clin Electrophysiol 2007; 30(5): 713-715.
51. Fish J.M., Antzelevitch C. Role of sodium and calcium chanell block in masking the Brugada syndrome. // Heart Rhythm 2004; 1: 210-217.
52. Kupriyanov V.V., Xiang B., Yang L., Deslauriers R. Lithium ion as a probe of Na+ channel activity in isolated rat hearts: a multinuclear NMR study. // NMR Biomed 1997; 10: 271-276.
53. Jo S.H., Youm J.B., Lee C.O. et al. Blocade of the HERG human cardiac K+ channel by the antidepressant drug amitriptyline. // Br J Pharmacol 2000; 129: 14741480.
54. Rampe D., Murawsky M.K., Grau et al. The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG. // J Pharmacol Exp Ther 1998; 286(2): 788-793.
55. Ogata N., Narahashi T. Block of sodium channels by psychotropic drugs in single guinea-pig cardiac myocytes. // Br J Pharmacol 1989; 97(3): 905-913.
56. Crumb W.J., Beasley C., Thornton A. et al. Cardiac ion channel blocking profile of olanzapine and other antipsychotics. Presented at the 38* American College of Neuropsychopharmacology Annual Meeting; Acapulco, Mexico; December 12-16, 1999.
57. W.E. Monteban-Kooistra , M.P. van den Berg , J.E. Tulleken et al. Brugada electrocardiographic pattern elicited by cyclic antidepressants overdose // Intensive Care Medicine 2006; 32(2): 281-285.
58. Tada H., Sticherling C., Oral H., Morady F. Brugada syndrome mimicked by tricyclic antidepressant overdose // J Cardiovasc Electrophysiol 2001; 12: 275. Casa report.
59. Chadwick B., Waller D.G., Edwards G. Potentially hazardous drug interactions with psychotics // Advances in Psychiatric Treatment 2005; 11: 440-449.
60. Rogers J.F., Nafziger A.N., Bertino J.S. Pharmacogenetics affects dosing, efficacy and toxicity of cytochrome P450 metabolized drugs // Amer J of Medicine 2002; 113: 746-750.
61. Meyer U. A. Genotype or phenotype: the definition of a pharmacogenetic polymorphism // Pharmacogenetics 1991; 1: 66-67.
62. Camm A. John. Drug-induced Long QT Syndrome // Vol.6, Futura Publishing Company, Inc., Armonk, NY, 2002: 20-24; 36.
63. Kiang T.K.L., Ensom M.H.H, Chang T.K.H. UDP-glucuronosyltransferases and clinical drug-drug intOeractions. // Pharmacology and Therapeutics 2005; 106: 97-132.
64. Lin J.H. and Yamazaki M. Role of P-glycoprotein in pharmacokinetics // Clinical Pharmacokinetics 2003; 42: 59-98.
65. Daniel W.A. Mechanisms of cellular distribution of psychotic drugs. Significance for drug action and interaction. // Progress in Neuropsychopharmacology and Biological Psychiatry 2003; 27: 65-73.
Рецензия
Для цитирования:
Лиманкина И.Н. СИНДРОМ БРУГАДА И БРУГАДОПОДОБНЫЕ ИЗМЕНЕНИЯ ЭКГ ПРИ ЛЕЧЕНИИ ПСИХОТРОПНЫМИ ПРЕПАРАТАМИ. Вестник аритмологии. 2007;(50):40-45.
For citation:
Limankina I.N. BRUGADA SYNDROME AND BRUGADA-LIKE ECG PATTERN DURING TREATMENT WITH PSYCHOACTIVE DRUGS. Journal of Arrhythmology. 2007;(50):40-45. (In Russ.)
Просмотров:
460
ISSN 1561-8641 (Print)
ISSN 2658-7327 (Online)
ISSN 2658-7327 (Online)
Послать статью по эл. почте 